Greg Schiffman will join StemCells as chief financial officer and executive vice president of finance in January.
Schiffman previously held financial executive posts at Affymetix and Applied Biosystems. He most recently was executive vice president and CFO of Dendreon.
StemCells is Newark, Calif.-based company that specializes in cell-based therapeutics and stem cell-based R&D firm. Schiffman will succeed StemCells' current CFO, Rodney Young, when he assumes his new post next year.